BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30654978)

  • 1. Stroke in patients with cardiovascular implantable electronic device infection undergoing transvenous lead removal.
    Lee JZ; Agasthi P; Pasha AK; Tarin C; Tseng AS; Diehl NN; Hodge DO; DeSimone CV; Killu AM; Brady PA; Kancharla K; Kusumoto FM; Srivathsan K; Osborn MJ; Espinosa RE; Rea RF; Madhavan M; McLeod CJ; Shen WK; Cha YM; Friedman PA; Asirvatham SJ; Mulpuru SK
    Heart Rhythm; 2018 Nov; 15(11):1593-1600. PubMed ID: 30654978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of cardiac implantable electronic device and patent foramen ovale in ischemic stroke: A case-only study.
    Agboola KM; Lee JM; Liu X; Novak E; Cuculich PS; Cooper DH; Noheria A
    Pacing Clin Electrophysiol; 2019 Mar; 42(3):341-348. PubMed ID: 30620091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac implantable electronic device infections: Who is at greatest risk?
    Joy PS; Kumar G; Poole JE; London B; Olshansky B
    Heart Rhythm; 2017 Jun; 14(6):839-845. PubMed ID: 28315744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of concomitant vacuum-assisted removal of lead-related vegetations and cardiac implantable electronic device extraction.
    Godara H; Jia KQ; Augostini RS; Houmsse M; Okabe T; Hummel JD; Weiss R; Kalbfleisch SJ; Afzal MR; Badin A; Cavalcanti R; Franco DA; Tyler J; Daoud EG
    J Cardiovasc Electrophysiol; 2018 Oct; 29(10):1460-1466. PubMed ID: 29964312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of timing of transvenous lead removal on outcomes in infected cardiac implantable electronic devices.
    Lee JZ; Majmundar M; Kumar A; Thakkar S; Patel HP; Sorajja D; Valverde AM; Kalra A; Cha YM; Mulpuru SK; Asirvatham SJ; Desimone CV; Deshmukh AJ
    Heart Rhythm; 2022 May; 19(5):768-775. PubMed ID: 34968739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and Short-Term Clinical Outcome of Mobile Thrombi Detected on Transvenous Leads in Patients Undergoing Lead Extraction.
    Ho G; Bhatia P; Mehta I; Maus T; Khoche S; Pollema T; Pretorius VG; Birgersdotter-Green U
    JACC Clin Electrophysiol; 2019 Jun; 5(6):657-664. PubMed ID: 31221351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical presentation and outcomes of cardiovascular implantable electronic device infections in hemodialysis patients.
    Hickson LJ; Gooden JY; Le KY; Baddour LM; Friedman PA; Hayes DL; Wilson WR; Steckelberg JM; Sohail MR
    Am J Kidney Dis; 2014 Jul; 64(1):104-10. PubMed ID: 24388672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Transvenous Lead Extraction for Cardiovascular Implantable Electronic Device Infections in Patients With Prosthetic Heart Valves.
    Huang XM; Fu HX; Zhong L; Cao J; Asirvatham SJ; Baddour LM; Sohail MR; Nkomo VT; Nishimura RA; Greason KL; Suri RM; Friedman PA; Cha YM
    Circ Arrhythm Electrophysiol; 2016 Sep; 9(9):. PubMed ID: 27635069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mobile thrombus on cardiac implantable electronic device leads of patients undergoing cardiac ablation: incidence, management, and outcomes.
    Sugrue A; DeSimone CV; Lenz CJ; Packer DL; Asirvatham SJ
    J Interv Card Electrophysiol; 2016 Aug; 46(2):115-20. PubMed ID: 26650730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of vegetation shape on outcomes in transvenous lead extractions: Does shape matter?
    Arora Y; Perez AA; Carrillo RG
    Heart Rhythm; 2020 Apr; 17(4):646-653. PubMed ID: 31756529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocardial pacemaker or defibrillator leads with infected vegetations: a single-center experience and consequences of transvenous extraction.
    Meier-Ewert HK; Gray ME; John RM
    Am Heart J; 2003 Aug; 146(2):339-44. PubMed ID: 12891205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
    Thompson AJ; Hagler DJ; Taggart NW
    Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
    Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
    Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for 1-year mortality among patients with cardiac implantable electronic device infection undergoing transvenous lead extraction: the impact of the infection type and the presence of vegetation on survival.
    Tarakji KG; Wazni OM; Harb S; Hsu A; Saliba W; Wilkoff BL
    Europace; 2014 Oct; 16(10):1490-5. PubMed ID: 25087154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate of cardiovascular implantable electronic device (CIED) re-extraction after recurrent infection.
    Saeed O; Gupta A; Gross JN; Palma EC
    Pacing Clin Electrophysiol; 2014 Aug; 37(8):963-8. PubMed ID: 24766634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality and Cerebrovascular Events After Heart Rhythm Disorder Management Procedures.
    Lee JZ; Ling J; Diehl NN; Hodge DO; Padmanabhan D; Killu AM; Madhavan M; Noseworthy PA; Kapa S; McLeod CJ; Cha YM; Deshmukh AJ; Srivathsan K; Kusumoto FM; Shen WK; Friedman PA; Munger TM; Asirvatham SJ; Packer DL; Mulpuru SK
    Circulation; 2018 Jan; 137(1):24-33. PubMed ID: 29046320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of infected cardiac implantable electronic devices.
    Chaudhry UA; Harling L; Ashrafian H; Athanasiou C; Tsipas P; Kokotsakis J; Athanasiou T
    Int J Cardiol; 2016 Jan; 203():714-21. PubMed ID: 26590887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
    Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL
    Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term mortality after transvenous lead extraction.
    Maytin M; Jones SO; Epstein LM
    Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):252-7. PubMed ID: 22362891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.